CALGB 50803 (Alliance): A phase 2 trial of lenalidomide plus rituximab in patients with previously untreated follicular lymphoma
- Citation:
- Hematol Oncol vol 31 (suppl 1) abstr 063
- Meeting Instance:
- ICML 2013
- Year:
- 2013
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Preliminary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2762
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- P. Martin S.-H. Jung J. Johnson R. Elstrom N. L. Bartlett K. Blum T. Shea J. Leonard B. Cheson
- Networks:
- Study
- CALGB-50803
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: